The IgG2 Isotype of Anti-Transcription Intermediary Factor 1γ Autoantibodies Is a Biomarker of Cancer and Mortality in Adult Dermatomyositis.
Audrey AussyManuel FréretLaure GallayDidier BessisThierry VincentDenis JullienLaurent DrouotFabienne JouenPascal JolyIsabelle MarieAlain MeyerJean SibiliaBrigitte Bader-MeunierEric HachullaMohammed HamidouSophie HuëJean-Luc CharuelNicole FabienPierre-Julien ViaillyYves AllenbachOlivier BenvenisteNadège CordelOlivier Boyernull nullPublished in: Arthritis & rheumatology (Hoboken, N.J.) (2019)
Our findings indicate that anti-TIF1γ IgG2 is a potential new biomarker of cancer that should be helpful in identifying the risk of mortality in anti-TIF1γ-positive DM patients.
Keyphrases
- papillary thyroid
- end stage renal disease
- squamous cell
- cardiovascular events
- ejection fraction
- childhood cancer
- chronic kidney disease
- systemic lupus erythematosus
- risk factors
- peritoneal dialysis
- prognostic factors
- lymph node metastasis
- transcription factor
- cardiovascular disease
- interstitial lung disease
- disease activity
- metabolic syndrome
- coronary artery disease
- skeletal muscle
- insulin resistance